Modifications of andrographolide to increase some biological activities: a patent review (2006 – 2011)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.2, 2012-02, pp. : 169-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)

By Probst Gary Xu Ying-zi

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 511-540

Informa Healthcare

Access to resources Recommend Favorite

Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 – 2011)

By Deng Xianming Choi Hwan Geun Buhrlage Sara J. Gray Nathanael S.

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1415-1426

Informa Healthcare

Access to resources Recommend Favorite

Nicotinic acetylcholine receptor ligands, a patent review (2006 – 2011)

By Gündisch Daniela Eibl Christoph

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1867-1896

Informa Healthcare

Access to resources Recommend Favorite

Biological Activities and Corresponding SARs of Andrographolide and Its Derivatives

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-02 ,pp. : 298-309

Bentham Science Publishers

Access to resources Recommend Favorite

Chemical Modifications and Biological Activities of Polysaccharides

Current Drug Targets, Vol. 17, Iss. 15, 2016-12 ,pp. : 1799-1803

Bentham Science Publishers

Access to resources Recommend Favorite